MET AMPLIFICATION

Clinical trials for MET AMPLIFICATION explained in plain language.

Never miss a new study

Get alerted when new MET AMPLIFICATION trials appear

Sign up with your email to follow new studies for MET AMPLIFICATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug duo aims to outsmart resistant lung cancer

Disease control Recruiting now

This study is testing whether adding a drug called savolitinib to a standard drug (osimertinib) can help control advanced lung cancer that has developed resistance to treatment. It is for adults whose cancer has specific genetic changes (EGFR mutation and low-level MET amplificat…

Matched conditions: MET AMPLIFICATION

Phase: PHASE2 • Sponsor: Qingdao Central Hospital • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

MET AMPLIFICATION

Get alerted when new MET AMPLIFICATION trials appear

New drug duo aims to outsmart resistant lung cancer